The heterogeneity of the neuronal distribution of exogenous noradrenaline in the rat vas deferens
- 1 August 1990
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 342 (2) , 160-170
- https://doi.org/10.1007/bf00166959
Abstract
After loading of the incubated rat vas deferens with 0.2 μmol/l 3H-noradrenaline (followed by 100 min of wash-out with amine-free solution), the efflux of endogenous and exogenous compounds was determined by HPLC with electrochemical detection and by column chromatography with scintillation counting. Two different types of heterogeneity of labelling were found. The first one is due to the preferential labelling of varicosities close to the surface of the tissue, the second one to the preferential labelling of vesicles close to the surface of loaded varicosities. As diffusion distances within the tissue and within varicosities are then longer for endogenous than for exogenous amine and metabolites, the composition of spontaneous efflux of exogenous compounds differed from that for endogenous compounds. Because of preferential neuronal and vesicular re-uptake of endogenous noradrenaline, the percentage contribution by noradrenaline to overall efflux was: endogenous < exogenous. While 3H-DOPEG was the predominant exogenous metabolite, DOPEG and MOPEG equally contributed to the “endogenous” efflux. Desipramine abolished the consequences of the first heterogeneity of labelling, i.e., it increased the efflux more for endogenous than for exogenous noradrenaline; moreover it decreased the efflux of 3H-DOPEG, but increased that of 3H-MOPEG. The reserpine-like compound Ro 41284, on the other hand, abolished the consequences of the second type of heterogeneity; it reduced the specific activity of “total efflux” (i.e., of the sum of noradrenaline + DOPEG + MOPEG) to the specific activity of the tissue noradrenaline. The degree of heterogeneity of labelling was reduced after inhibition of monoamine oxidase and also when the tissues were loaded with 2 or 20 μmol/l 3H-noradrenaline. It is proposed that the various “compartments” and “pools” of noradrenaline described in the literature reflect the two heterogeneities described here.Keywords
This publication has 34 references indexed in Scilit:
- Mechanisms of the release of 3H-noradrenaline by dimethylphenylpiperazinium (DMPP) in the rat vas deferensNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
- Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycolJournal of the Autonomic Nervous System, 1988
- Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stressLife Sciences, 1988
- The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenalineNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1987
- Uptake of tyramine into synaptic vesicles of the caudate nucleusNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1977
- Preferential metabolism of (—)-3H-norepinephrine through the deaminated glycol in the rat vas deferensBiochemical Pharmacology, 1973
- Differential labelling of intraneuronal noradrenaline stores with different concentrations of (–)‐3H‐noradrenalineBritish Journal of Pharmacology, 1973
- Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamineBritish Journal of Pharmacology, 1972
- Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferensBritish Journal of Pharmacology, 1969
- THE DISTRIBUTION OF LABELED NOREPINEPHRINE WITHIN SYMPATHETIC NERVE TERMINALS STUDIED WITH ELECTRON MICROSCOPE RADIOAUTOGRAPHYThe Journal of cell biology, 1969